Management of Drug Interactions with Inducers: Onset and Disappearance of Induction on Cytochrome P450 3A4 and Uridine Diphosphate Glucuronosyltransferase 1A1 Substrates

BACKGROUND: People living with HIV may present co-morbidities requiring the initiation and subsequently the discontinuation of medications with inducing properties. The time to reach maximal enzyme induction and to return to baseline enzyme levels has not been thoroughly characterized. OBJECTIVE: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bettonte, Sara, Berton, Mattia, Stader, Felix, Battegay, Manuel, Marzolini, Catia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322778/
https://www.ncbi.nlm.nih.gov/pubmed/37278880
http://dx.doi.org/10.1007/s13318-023-00833-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322778/
https://www.ncbi.nlm.nih.gov/pubmed/37278880
http://dx.doi.org/10.1007/s13318-023-00833-9

Ejemplares similares